Resistance of the myocardium to ischemia and the efficacy of ischemic preconditioning in experimental diabetes mellitus
Data on the influences of diabetes mellitus on the severity of ischemic damage to the myocardium are contradictory. We report here experiments using a model based on in vivo myocardial infarcts resulting from coronary occlusion to study the resistance of the myocardium in rats with alloxan-induced insulin-dependent diabetes mellitus to prolonged ischemia, along with studies of the infarct-limiting efficacy of ischemic preconditioning. The results showed that after diabetes mellitus for six weeks, the relative size of infarcts was significantly less than in controls (39.8 ± 8.8 and 62.3 ± 6.6% of the size of the anatomical risk zone respectively, p < 0.01). In addition, animals with diabetes mellitus developed ischemic ventricular tachyarrhythmia significantly less often than controls. A single episode of ischemic preconditioning in animals with diabetes mellitus had a less marked infarct-limiting effect than the same procedure in controls. Thus, these data support the existence of an endogenous cardioprotective phenotype (metabolic preconditioning) in experimental diabetes. On the other hand, the efficacy of ischemic preconditioning was sharply decreased in diabetes.
Key wordsheart ischemia myocardial infarct preconditioning diabetes mellitus
Unable to display preview. Download preview PDF.
- 1.N. N. Petrishchev, E. V. Shlyakhto, T. D. Vlasov, and M. M. Galagudza, “Ischemic adaptation of the myocardium: pathophysiological mechanisms and possible potentials for practical application (literature review),” Ros. Fiziol. Zh. im. I. M. Sechenova, 87, No. 5, 688–705 (2001).Google Scholar
- 6.A. M. Murcia, C. H. Hennekens, G. A. Lamas, M. Jimenez-Navarro, J. L. Rouleau, G. C. Flaker, S. Goldman, H. Skali, E. Braunwald, and M. A. Pfeffer, “Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction,” Arch, Intern. Med., 164, No. 20, 2273–2279 (2004).CrossRefGoogle Scholar
- 9.T. Ravingerova, J. Neckar, and F. Kolar, “Ischemic tolerance of rat hearts in acute and chronic phases of experimental diabetes,” Mol. Cell. Biochem., 249, No. 1–2, 164–174 (2003).Google Scholar
- 11.P. H. Stone, J. E. Muller, T. Hartwell, B. J. York, J. D. Rutherford, C. B. Parker, Z. G. Turi, H. W. Strauss, J. T. Willerson, and T. Robertson, “The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infraction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group,” Amer. J. Cell. Cardiol., 14, No. 1, 49–57 (1989).CrossRefGoogle Scholar
- 13.M. J. Walker, M. J. Curtis, D. J. Hearse, R. W. Campbell, M. J. Jance, D. M. Yellon, S. M. Cobbe, S. J. Coker, J. B. Harness, D. W. Harron, A. J. Higgins, D. G. Julian, M. L. Lab, A. S. Manning, B. J. Northover, J. R. Parratt, R. A. Riemersma, E. Riva, D. C. Russell, D. J. Sheridan, E. Winslow, and B. Woodward, “The Lambeth Conventions: guidelines for the study of arrhythmias in ischemia, infarction, and reperfusion,” Cardiovasc. Res., 22, No. 7, 447–455 (1988).PubMedCrossRefGoogle Scholar